David Robert Baldinger, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 14171 Metropolis Ave Ste 101, Fort Myers, FL 33912 Phone: 239-320-8140 Fax: 239-320-8141 |
Dr. Edwin Michel Aquino, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 8960 Colonial Center Dr Ste 302, Fort Myers, FL 33905 Phone: 239-343-9633 Fax: 239-343-4015 |
Melissa Brauner Blom, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 14171 Metropolis Ave Ste 101, Fort Myers, FL 33912 Phone: 239-320-8140 Fax: 239-320-8141 |
Kalugamage Ranjit Fernando, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 3722 Central Ave, Suite 2, Fort Myers, FL 33901 Phone: 239-936-1920 Fax: 239-936-0371 |
Marielys Del Carmen Figueroa Sierra, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 8960 Colonial Center Dr Ste 302, Fort Myers, FL 33905 Phone: 239-343-9633 Fax: 239-343-4015 |
Jodi M Grosflam, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 15740 New Hampshire Ct, Suite B, Fort Myers, FL 33908 Phone: 239-415-1100 |
News Archive
MagnaChip Semiconductor Corporation ("MagnaChip"), a Korean semiconductor company with a broad portfolio of analog and mixed-signal products and technologies, today announced a full range of "MXsensor" intelligent sensor product families featuring 0.18 micron mixed signal & analog technology with low power consumption.
UT Southwestern researchers have found that an enzyme on the surface of some lung cancer cells helps feed the cancer, making it a tempting treatment target.
Adults in the UK who have poor sleep patterns are more likely to be overweight and obese and have poorer metabolic health, according to a new study.
The programs are known as Physician Orders for Life-Sustaining Treatment, or Polst. They are meant to complement advance directives, sometimes known as living wills, in which people state in broad terms how much medical intervention they will want when their condition no longer allows them to communicate.
Zcube, Srl, the research venture of Italian pharmaceutical company Zambon Co., SpA, and Arizona Technology Enterprises (AzTE), the technology venturing arm of Arizona State University, have entered into a licensing agreement that will allow Zcube to use ASU technology to develop and commercialize next-generation medical devices that can better monitor and treat chronic respiratory diseases like asthma.
› Verified 6 days ago